The Secret to Longer Life Could be Selflessness, Scientists Say
Extra Vitamin D and Calcium Aren’t Needed, Report Says
Robotic Assist Eases Less-Invasive Hysterectomies
Probiotics May Have Some Benefits for Kids
Alcoholic Whipped Cream: Another Binge Drink in a Can?
Read the rest of this entry »
Posted in Uncategorized
Ex-Glaxo Exectutive is Charged in Drug Fraud
Many Obese Teens Put on Even More Weight as Young Adults
Lung Cancer in a Smoker May be Different Than Lung Cancer in a Nonsmoker
Takeda Says No Interest in Generic Drug Market
Allergan to Shift Headache Sales Reps to Botox
A Direct Hit of Drugs to Treat Brain Cancer
New Lines Attack in HIV Prevention
Overweight Children Show More Signs of Stress
Gene Research Finds Clues to AIDS survival
Quick Study: Colds Seem Less Common and Severe Among Those Who Exercise Most
Antibiotics Research Subsidies Weighed by U.S.
Exercise Fights the Common Cold, Study Finds
Scan Found to Lower Chances of Lung Cancer Deaths
Glaxo Breathes Easier as Threat to Advair Recedes
Obama Administation Retools New Health Program
Do Parents Discrimitate Against There Own Chubby Children?
Nestle Seeks to Expand in Healthcare Nutrition
Biotech Companies Counting On Stem Cells
$93,000 cancer drug: How much is a life worth?
Health Insurer Rule Draft Yields Few Surprises?
House Passes Plan to Stop Medicare Cuts to Doctors
J&J Plant Involved in Recall to Stay Closed
P&G Recalls Nasal Spray Sold in U.S. Stores
Kowa’s US CEO Says New Statin Holds Appeal for Untreated Patients
Native Americans Embrace Tradition to Defeat Diabetes
Obesity Task Force Urges Action
U.S. Group Urges FDA to Halt Glaxo’s Avandia Trial
Health Overhaul Law Potentially Costs $115B More
First Lady Releases Child Obesity Recommendations
Merck: Schering-Plough Integration is on Track
How’s My Detailing? Dial 1-877-RX-DDMAC
Consumers Want Unbranded Sites, Despite FDA Warnings
Colin Powell and Bill Gates Join Malaria Campaign
Merck Inks Deal on Tetanus, Diphtheria Vaccine
Abbott First-Quarter Profit Falls as Costs Increase
Senate Bill Sets a Plan to Regulate Premiums
Drug Maker Elan Narrows Loss Read the rest of this entry »
Changing Old Habits Could Save Big On Drug Costs
Biogen First-Quarter Profit Drops on Higher Research
J&J First-Quarter Profit Rises on Device Sales Gains
Benefit for Uninsured May Still Pose Hurdle
Cancer Fight: Unclear Tests for New Drug Read the rest of this entry »
Usana 4Q profit doubles on lower general costs (Associated Press)
GSK reveals plans to trim workforce at UK research site (Pharmatimes.com)
Sanofi-Aventis Q4 Profit Up on Swine Flu Vaccines (Associated Press)
Blow for Novartis and B-MS as NICE rejects Afinitor, Tasigna and Sprycel (Pharmatimes.com)
Posted in Industry Stories, Uncategorized
Older Posts
SUBSCRIBE
SUBSCRIBE